$CLOW
Cloudweb, Inc.

2022 Q2 Form 10-Q Financial Statement

#000164033422000928 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.500K $19.30K $17.05K
YoY Change 79.25% 13.2% -99.85%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses -$9.635K $19.30K $17.05K
YoY Change -2.0% 13.2% -99.85%
Operating Profit -$9.728K -$9.730K
YoY Change -0.02%
Interest Expense $9.635K $9.728K $9.730K
YoY Change -2.0% -0.02% -129.95%
% of Operating Profit
Other Income/Expense, Net -$9.635K -$9.728K
YoY Change
Pretax Income -$19.14K -$29.03K -$26.78K
YoY Change 26.5% 8.4% -99.77%
Income Tax
% Of Pretax Income
Net Earnings -$19.14K -$29.03K -$26.78K
YoY Change 26.45% 8.39% -99.77%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$705.60 -$1.394K -$84.83K
COMMON SHARES
Basic Shares Outstanding 27.82M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.61K $57.51K $56.16K
YoY Change 11.09% 2.4%
Accrued Expenses $162.8K $153.7K $116.7K
YoY Change 29.26% 31.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $155.6K $157.6K $42.14K
YoY Change -0.08% 273.9%
Total Short-Term Liabilities $438.3K $421.7K $231.3K
YoY Change 21.93% 82.3%
LONG-TERM LIABILITIES
Long-Term Debt $67.33K $67.33K $180.3K
YoY Change 0.0% -62.66%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $67.33K $67.33K $180.3K
YoY Change 0.0% -62.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $438.3K $421.7K $231.3K
Total Long-Term Liabilities $67.33K $67.33K $180.3K
Total Liabilities $505.6K $489.0K $411.6K
YoY Change 18.47% 18.79%
SHAREHOLDERS EQUITY
Retained Earnings -$233.3M
YoY Change
Common Stock $237.9M $104.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$505.6K -$489.0K -$411.6K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$19.14K -$29.03K -$26.78K
YoY Change 26.45% 8.39% -99.77%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$7.400K -$17.90K -$16.30K
YoY Change -5.13% 9.82% 241.72%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.400K $17.90K $16.30K
YoY Change -5.13% 9.82% 241.72%
NET CHANGE
Cash From Operating Activities -7.400K -$17.90K -$16.30K
Cash From Investing Activities 0.000
Cash From Financing Activities 7.400K $17.90K $16.30K
Net Change In Cash 0.000 $0.00 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$7.400K -$17.90K -$16.30K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25319385 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
319385 shares
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-96216 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27819385 shares
CY2022Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
584 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1184 USD
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
67326 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-96216 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
9728 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
9730 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9728 USD
CY2021Q1 clow Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.08
CY2022Q1 clow Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
20825003 shares
CY2021Q1 clow Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
315703 shares
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9730 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-459946 USD
CY2022Q1 clow Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-29028 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-488974 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-384858 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-26780 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
29028 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
26780 USD
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
600 USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
597 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1397 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
753 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9131 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9130 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17900 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16300 USD
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
17900 USD
CY2021Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
16300 USD
CY2022Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2021Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17900 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16300 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2022Q1 us-gaap Stock Issued1
StockIssued1
104250000 USD
CY2021Q1 us-gaap Stock Issued1
StockIssued1
0 USD
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
154798 USD
CY2022Q1 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-155398 USD
CY2021Q4 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-154798 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
57827097 shares
CY2021Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
57827097 shares
CY2022Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
17900 USD
CY2021Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
16300 USD
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
52860 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
34960 USD
CY2022Q1 clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 USD
CY2021 clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 USD
CY2022Q1 clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 USD
CY2021 clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 USD
CY2022Q1 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
73046 USD
CY2021 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
67672 USD
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
600 USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
597 USD
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
154798 USD
CY2021Q4 clow Less Debt Discount
LessDebtDiscount
-1184 USD
CY2022Q1 us-gaap Convertible Debt
ConvertibleDebt
155398 USD
CY2022Q1 clow Less Debt Discount
LessDebtDiscount
-584 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
584 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
1184 USD
CY2022Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
80678 USD
CY2021Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
76921 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25000000 shares
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
104250000 USD
CY2022Q2 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
6074 USD
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2500000 shares

Files In Submission

Name View Source Status
0001640334-22-000928-index-headers.html Edgar Link pending
0001640334-22-000928-index.html Edgar Link pending
0001640334-22-000928.txt Edgar Link pending
0001640334-22-000928-xbrl.zip Edgar Link pending
clow-20220331.xsd Edgar Link pending
clow-20220331_cal.xml Edgar Link unprocessable
clow-20220331_def.xml Edgar Link unprocessable
clow-20220331_lab.xml Edgar Link unprocessable
clow-20220331_pre.xml Edgar Link unprocessable
clow_10q.htm Edgar Link pending
clow_10q_htm.xml Edgar Link completed
clow_ex311.htm Edgar Link pending
clow_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending